aXichem AB (AXIC-A.ST) Stock Analysis & Winston Score
aXichem AB is a Swedish specialty chemicals company focused on developing and commercializing phenylcapsaicin, a synthetic version of the compound that makes chili peppers hot. The company targets two main markets: animal nutrition, where phenylcapsaicin is sold as a feed additive to improve livestock performance, and human health and wellness products. aXichem holds patents on its synthetic phenylcapsaicin technology, which distinguishes it from natural capsaicin suppliers. The company generates revenue by selling its phenylcapsaicin ingredient to feed producers, supplement makers, and other industrial customers, though sales remain small and early-stage. aXichem operates primarily out of Sweden and sells into European and international markets, but it is a micro-cap company still working toward consistent profitability, as shown by its negative margins. The key growth driver is broader commercial adoption of phenylcapsaicin in animal feed, but the main risk is that the company burns through cash before achieving the sales volume needed to cover its operating costs.
Winston Score: 23/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Mixed (6/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $1.31
Market Cap: $89M
Sector: Basic Materials
Industry: Chemicals - Specialty
Exchange: Stockholm Stock Exchange


